• Choby JE, Howard‐Anderson J, Weiss DS. Hypervirulent Klebsiella pneumoniae–clinical and molecular perspectives. J Intern Med 2020; 287(3): 283-300. doi: 10.1111/joim.13007.
• Logan LK, Weinstein RA. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis 2017; 215(suppl_1): S28-S36. doi: 10.1093/infdis/jiw282.
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018; 18(3): 318-27. doi: 10.1016/S1473-3099(17)30753-3.
• Zarakolu P, Eser OK, Aladag E, et al. Epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization: a surveillance study at a Turkish university hospital from 2009 to 2013. Diagn Microbiol Infect Dis 2016; 85(4): 466-70. doi: 10.1016/j.diagmicrobio.2016.05.012.
• Chen C-M, Guo M-K, Ke S-C, et al. Emergence and nosocomial spread of ST11 carbapenem-resistant Klebsiella pneumoniae co-producing OXA-48 and KPC-2 in a regional hospital in Taiwan. J Med Microbiol 2018; 67(7): 957-64. doi: 10.1099/jmm.0.000771.
• Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48(1): 15-22. doi: 10.1128/AAC.48.1.15-22.2004.
• Nordmann P, Gniadkowski M, Giske C, et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18(5): 432-8. doi: 10.1111/j.1469-0691.2012.03815.x.
• Sağıroğlu P, Hasdemir U, Gelmez GA, Aksu B, Karatuna O, Söyletir G. Performance of “RESIST-3 OKN K-SeT” immunochromatographic assay for the detection of OXA-48 like, KPC, and NDM carbapenemases in Klebsiella pneumoniae in Turkey. Braz J Microbiol 2018; 49(4): 885-90. doi: 10.1016/j.bjm.2018.02.002.
• Genc O, Aksu E. Chromogenic culture media or rapid immunochromatographic test: which is better for detecting Klebsiella pneumoniae that produce OXA-48 and can they be used in blood and urine specimens. J Microbiol Methods 2018; 148: 169-73. doi: 10.1016/j.mimet.2018.04.014.
• Meng X, Yang J, Duan J, et al. Assessing molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China. Sci Rep 2019; 9(1): 1-9. doi: 10.1038/s41598-018-38295-8.
• Livorsi DJ, Chorazy ML, Schweizer ML, et al. A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control 2018; 7(1): 55. doi: 10.1186/s13756-018-0346-9.
• Grundmann H, Glasner C, Albiger B, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis 2017; 17(2): 153-63. doi: 10.1016/S1473-3099(16)30257-2.
• Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Eurosurveillance 2015; 20(45): 30062. doi: 10.2807/1560-7917.ES.2015.20.45.30062.
• Brolund A, Lagerqvist N, Byfors S, et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Eurosurveillance 2019; 24(9): 1900123. doi: 10.2807/1560-7917.ES.2019.24.9.1900123.
• Glasner C, Albiger B, Buist G, et al. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. Eurosurveillance 2013; 18(28): 20525. doi: 10.2807/1560-7917.ES2013.18.28.20525.
• Davarci I, Senbayrak S, Aksaray S, et al. Molecular Epidemiology of Carbapenemresistant Klebsiella pneumoniae Isolates. Anatolian Clinic 2019; 24(1): 1-7. doi: 10.21673/anadoluklin.423081.
• Woodford N, Pike R, Meunier D, Loy R, Hill R, Hopkins KL. In vitro activity of temocillin against multidrug-resistant clinical isolates of Escherichia coli, Klebsiella spp. and Enterobacter spp., and evaluation of high-level temocillin resistance as a diagnostic marker for OXA-48 carbapenemase. J Antimicrob Chemother 2014; 69(2): 564-7. doi: 10.1093/jac/dkt383.
• Shaker OA, Gomaa HE, Elmasry SA, Halim RMA, Abdelrahman AH, Kamal JS. Evaluation of Combined Use of Temocillin Disk and Mastdisks Inhibitor Combination Set Against Polymerase Chain Reaction for Detection of Carbapenem-Resistant Enterobacteriaceae. Open Access Maced J Med Sci 2018; 6(2): 242-7. doi: 10.3889/oamjms.2018.090.
• Kolenda C, Benoit R, Carricajo A, Bonnet R, Dauwalder O, Laurent F. Evaluation of the new multiplex immunochromatographic OKNV K-Set assay for the rapid detection of OXA-48-like, KPC, NDM and VIM carbapenemases. J Clin Microbiol 2018; 56(11): e01247-18. doi: 10.1128/JCM.01247-18.
• Rubio E, Zboromyrska Y, Pitart C, et al. Evaluation of a rapid immunochromatographic test for the detection of OXA-48 carbapenemase. Diagn Microbiol Infect Dis 2017; 87(3): 266-7. doi: 10.1016/j.diagmicrobio.2016.12.001.
• Koroska F, Göttig S, Kaase M, et al. Comparison of phenotypic tests and an immunochromatographic assay and development of a new algorithm for detection of OXA-48-like carbapenemases. J Clin Microbiol 2017; 55(3): 877-83. doi: 10.1128/JCM.01929-16.
• Wareham DW, Shah R, Betts JW, Phee LM, Momin MHFA. Evaluation of an immunochromatographic lateral flow assay (OXA-48 K-SeT) for rapid detection of OXA-48-like carbapenemases in Enterobacteriaceae. J Clin Microbiol 2016; 54(2): 471-3. doi: 10.1128/JCM.02900-15.
• Girlich D, Anglade C, Zambardi G, Nordmann P. Comparative evaluation of a novel chromogenic medium (chromID OXA-48) for detection of OXA-48 producing Enterobacteriaceae. Diagn Microbiol Infect Dis 2013; 77(4): 296-300. doi: 10.1016/j.diagmicrobio.2013.08.015.
• Zarakolu P, Day K, Sidjabat H, et al. Evaluation of a new chromogenic medium, chromID OXA-48, for recovery of carbapenemase-producing Enterobacteriaceae from patients at a university hospital in Turkey. Eur J Clin Microbiol Infect Dis 2015; 34(3): 519-25. doi: 10.1007/s10096-014-2255-z.

Vancouver

Sanmak E, Aksaray S. Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains. J CLIN EXP INVEST. 2021;12(4):em00778. https://doi.org/10.29333/jcei/11267

APA

Sanmak, E., & Aksaray, S. (2021). Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains. Journal of Clinical and Experimental Investigations, 12(4), em00778. https://doi.org/10.29333/jcei/11267

AMA

Sanmak E, Aksaray S. Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains. J CLIN EXP INVEST. 2021;12(4), em00778. https://doi.org/10.29333/jcei/11267

Chicago

Sanmak, Erkan, and Sebahat Aksaray. "Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains". Journal of Clinical and Experimental Investigations 2021 12 no. 4 (2021): em00778. https://doi.org/10.29333/jcei/11267

Harvard

Sanmak, E., and Aksaray, S. (2021). Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains. Journal of Clinical and Experimental Investigations, 12(4), em00778. https://doi.org/10.29333/jcei/11267

MLA

Sanmak, Erkan et al. "Comparison of Chromogenic Culture Media, Rapid Immunochromatographic Test and Temocillin Resistance for The Detection of OXA-48 Carbapenemase-Positive Klebsiella Pneumonia Strains". Journal of Clinical and Experimental Investigations, vol. 12, no. 4, 2021, em00778. https://doi.org/10.29333/jcei/11267